S. 1182 · 118th Congress
340B Reporting and Accountability Act
Key: what the circles and colors mean
Each circle is a bill. The ring fills as it moves through Congress:
Under the number: the Yea · Nay count of its final (or latest) recorded vote. On a member's page, the small badge is how that member voted: Y Yea / Aye, N Nay / No, P Present, – Not voting.
Gold and violet are only for Yea and Nay; they never mean a party. A member's party is the letter on their photo.
Never voted on. It didn't reach a floor vote before the 118th Congress ended, so it expired. A bill has to be introduced again to be considered in a new Congress.
R
KennedySponsorNo cosponsors.
This bill requires providers participating in the 340B drug discount program to ensure patients receive covered outpatient drugs at a price that does not exceed the amount the provider paid, minus any additional discounts or rebates the provider receives.
What it does: CRS summary · Introduced in Senate · Apr 18, 2023
340B Reporting and Accountability Act
This bill requires providers participating in the 340B drug discount program to ensure patients receive covered outpatient drugs at a price that does not exceed the amount the provider paid, minus any additional discounts or rebates the provider receives.
Further, participating providers must report annually information about amounts paid and received for covered outpatient drugs and how any excess revenue was spent.
Written by the nonpartisan Congressional Research Service. All summary versions on Congress.gov
About this bill and sources
Official title: 340B Reporting and Accountability Act
Latest action (Apr 18, 2023): Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Policy area: Health · Origin: Senate · Introduced: Apr 18, 2023
Official page on Congress.gov · Bill text (GovInfo) · Status record (XML)
No recorded floor vote found.